Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Bioanalysis
|
May 23, 2020
Challenges and recommendations in developing LC-MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites
Long Yuan, Xiaohui Sophia Xu, Qin C Ji
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 29, 2005
Quantitative determination of a novel dual PPAR alpha/gamma agonist using on-line turbulent flow extraction with liquid chromatography-tandem mass spectrometry
Xiaohui Sophia Xu, Kerri X Yan, Hengchang Song, et al.
Bioanalysis
|
February 27, 2014
Sensitivity-based analytical approaches to support human absolute bioavailability studies
Xiaohui Sophia Xu, Hao Jiang, Lisa J Christopher, et al.
Bioanalysis
|
December 23, 2014
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples
Xiaohui Sophia Xu, Anne Rose, Roger Demers, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 20, 2010
Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra) in human plasma: method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degradants
Xiaohui Sophia Xu, Jianing Zeng, William Mylott, et al.
British Journal of Clinical Pharmacology
|
July 25, 2012
Simultaneous oral therapeutic and intravenous ¹⁴C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin
David W Boulton, Sreeneeranj Kasichayanula, Chi Fung Anther Keung, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 22, 2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations
Xiaohui Sophia Xu, Roger Demers, Huidong Gu, et al.
Bioanalysis
|
September 5, 2012
Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS
Xiaohui Sophia Xu, Stephen R Dueker, Lisa J Christopher, et al.
Clinical Pharmacology and Therapeutics
|
December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group
Wenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
The AAPS Journal
|
July 1, 2026
Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
Jim X Shen, Robert Dodge, Shoshana Oberstein, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Bioanalysis
|
May 23, 2020
Challenges and recommendations in developing LC-MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites
Long Yuan, Xiaohui Sophia Xu, Qin C Ji
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 29, 2005
Quantitative determination of a novel dual PPAR alpha/gamma agonist using on-line turbulent flow extraction with liquid chromatography-tandem mass spectrometry
Xiaohui Sophia Xu, Kerri X Yan, Hengchang Song, et al.
Bioanalysis
|
February 27, 2014
Sensitivity-based analytical approaches to support human absolute bioavailability studies
Xiaohui Sophia Xu, Hao Jiang, Lisa J Christopher, et al.
Bioanalysis
|
December 23, 2014
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples
Xiaohui Sophia Xu, Anne Rose, Roger Demers, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 20, 2010
Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra) in human plasma: method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degradants
Xiaohui Sophia Xu, Jianing Zeng, William Mylott, et al.
British Journal of Clinical Pharmacology
|
July 25, 2012
Simultaneous oral therapeutic and intravenous ¹⁴C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin
David W Boulton, Sreeneeranj Kasichayanula, Chi Fung Anther Keung, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 22, 2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations
Xiaohui Sophia Xu, Roger Demers, Huidong Gu, et al.
Bioanalysis
|
September 5, 2012
Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS
Xiaohui Sophia Xu, Stephen R Dueker, Lisa J Christopher, et al.
Clinical Pharmacology and Therapeutics
|
December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group
Wenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
The AAPS Journal
|
July 1, 2026
Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
Jim X Shen, Robert Dodge, Shoshana Oberstein, et al.
Page
of 1